Declining Fertility Confirmed in Austrian Study
Austrian Government Study Confirms Genetically Modified 
Threaten Human Fertility and Health Safety 
Advocates Call for Immediate Ban of GM Foods and Crops
​A long-term feeding study commissioned by the Austrian Agency for Health and Food Safety, managed by the Austrian Federal Ministry of Health, Family and Youth, and carried out by Veterinary University Vienna, confirms genetically modified (GM) corn seriously affects reproductive health in mice. Non-GMO advocates, who have warned about this infertility link along with other health risks, now seek an immediate ban of all GM foods and GM crops to protect the health of humankind and the fertility of women around the world.
Feeding mice with genetically modified corn developed by the US-based Monsanto Corporation led to lower fertility and body weight, according to the study conducted by the University of Veterinary Medicine in Vienna. Lead author of the study Professor Zentek said, there was a direct link between the decrease in fertility and the GM diet, and that mice fed with non-GE corn reproduced more efficiently.
In the study, Austrian scientists performed several long-term feeding trials over 20 weeks with laboratory mice fed a diet containing 33% of a GM variety (NK 603 x MON 810), or a closely related non-GE variety used in many countries. Statistically significant litter size and pup weight decreases were found in the third and fourth litters in the GM-fed mice, compared to the control group.  

Do you have a deficiency of Crestor?
NO, you don’t. Results of a Crestor-sponsored study found that normally healthy people should take Crestor, even without higher cholesterol  Really??? 
Be skeptical, people. Here’s why: Crestor, one of the most powerful statin drugs made by AstraZeneca, was heralded by a company press release, (which was picked up by numerous media outlets without question, except for ABC) for bringing about a 56% reduction in cardiovascular events (heart attack, stroke, etc.)  most likely due to a reduction of these pro-inflammatory substances such as C-reactive protein (CRP), interleukin and cytokines. 
This 56% is one of those sneaky statistical smokescreens--sounds better than it is. The difference between one group taking Crestor and another taking a placebo was actually 2.8% versus 1.6%. In other words, a 56% difference. It’s better to analyze the composite outcome, which tells you that if you had 100 people on Crestor, about .77 would have a cardiovascular event within a year, compared to 1.35 out of 100, for those not on the drug.